Downloads: 1
201 lines (200 with data), 7.0 kB
T1 Age 2 13 48-year-old T2 Sex 14 17 man T3 Clinical_event 18 27 presented E1 Clinical_event:T3 T4 Nonbiological_location 35 43 hospital R1 MODIFY Arg1:T4 Arg2:E1 T5 Sign_symptom 72 78 bruits E2 Sign_symptom:T5 T6 Biological_structure 59 71 intracranial R2 MODIFY Arg1:T6 Arg2:E2 T7 Diagnostic_procedure 102 125 laboratory examinations E3 Diagnostic_procedure:T7 T8 Diagnostic_procedure 84 97 cranial nerve E4 Diagnostic_procedure:T8 T9 Lab_value 131 137 normal R3 MODIFY Arg1:T9 Arg2:E3 R4 MODIFY Arg1:T9 Arg2:E4 T10 Disease_disorder 141 145 DVAF E5 Disease_disorder:T10 A1 POLARITY E5 UNCERTAIN T11 Diagnostic_procedure 162 206 conventional digital subtraction angiography E6 Diagnostic_procedure:T11 T12 Disease_disorder 237 252 Cognard II DVAF E7 Disease_disorder:T12 T13 Biological_structure 272 295 right hypoglossal canal R5 MODIFY Arg1:T13 Arg2:E7 T14 Biological_structure 297 299 HC R6 IDENTICAL Arg1:T14 Arg2:T13 T15 Coreference 306 310 DVAF E8 Coreference:T15 R7 IDENTICAL Arg1:E8 Arg2:E7 T16 Biological_structure 326 344 meningeal branches T17 Biological_structure 352 391 bilateral ascending pharyngeal arteries R8 MODIFY Arg1:T17 Arg2:T16 T18 Biological_structure 401 430 right anterior condylar veins T19 Biological_structure 442 459 hypoglossal canal R9 MODIFY Arg1:T19 Arg2:T18 T20 Sign_symptom 473 488 fistulous point E9 Sign_symptom:T20 R10 MODIFY Arg1:T18 Arg2:E9 R11 MODIFY Arg1:T16 Arg2:E8 T21 Detailed_description 496 525 drained into the jugular vein R12 MODIFY Arg1:T21 Arg2:E9 T22 Therapeutic_procedure 527 549 Endovascular treatment E10 Therapeutic_procedure:T22 T23 Coreference 634 639 bruit E11 Coreference:T23 R13 IDENTICAL Arg1:E11 Arg2:E2 T24 Biological_structure 621 633 intracranial R14 MODIFY Arg1:T24 Arg2:E11 T25 Detailed_description 609 620 intolerable R15 MODIFY Arg1:T25 Arg2:E11 T26 Therapeutic_procedure 668 690 transarterial approach E12 Therapeutic_procedure:T26 R16 SUB_PROCEDURE Arg1:E12 Arg2:E10 T27 Medication 697 715 general anesthesia E13 Medication:T27 R17 MODIFY Arg1:E13 Arg2:E12 T28 Therapeutic_procedure 724 749 biplane angiographic unit E14 Therapeutic_procedure:T28 R18 SUB_PROCEDURE Arg1:E14 Arg2:E10 T29 Therapeutic_procedure 751 778 Standard coaxial techniques E15 Therapeutic_procedure:T29 R19 SUB_PROCEDURE Arg1:E15 Arg2:E10 T30 Therapeutic_procedure 794 822 guide catheter was navigated E16 Therapeutic_procedure:T30 T31 Biological_structure 832 869 left ascendingtrawt pharyngeal artery R20 MODIFY Arg1:T31 Arg2:E16 T32 Therapeutic_procedure 1019 1044 microcatheter was flushed E17 Therapeutic_procedure:T32 T33 Volume 1050 1055 10 mL T34 Biological_structure 1059 1072 normal saline R21 MODIFY Arg1:T33 Arg2:T34 R22 MODIFY Arg1:T34 Arg2:E17 T35 Therapeutic_procedure 871 935 Marathon flow directed catheter (eV3) was subsequently navigated E18 Therapeutic_procedure:T35 T36 Sign_symptom 1006 1013 fistula E19 Sign_symptom:T36 R23 MODIFY Arg1:E19 Arg2:E18 T37 Diagnostic_procedure 1407 1416 angiogram E20 Diagnostic_procedure:T37 T38 Detailed_description 1397 1406 follow-up R24 MODIFY Arg1:T38 Arg2:E20 T39 Sign_symptom 1427 1441 residual shunt E21 Sign_symptom:T39 A2 POLARITY E21 NEG T40 Biological_structure 1459 1471 intracranial T41 Sign_symptom 1472 1478 bruits E22 Sign_symptom:T41 R25 MODIFY Arg1:T40 Arg2:E22 A3 POLARITY E22 NEG T42 Dosage 1550 1555 10 mg T43 Medication 1556 1569 dexamethasone E23 Medication:T43 T44 Administration 1574 1596 intravenously injected T45 Duration 1601 1611 three days E24 Duration:T45 T46 Date 1620 1659 second day after endovascular treatment E25 Date:T46 T47 Sign_symptom 1688 1716 difficulty moving his tongue E26 Sign_symptom:T47 T48 Diagnostic_procedure 1744 1755 examination E27 Diagnostic_procedure:T48 T49 Biological_structure 1730 1743 Cranial nerve R26 MODIFY Arg1:T49 Arg2:E27 T50 Sign_symptom 1783 1812 right hypoglossal nerve palsy E28 Sign_symptom:T50 T51 Clinical_event 1830 1840 discharged E29 Clinical_event:T51 T52 Nonbiological_location 1850 1858 hospital T53 Date 1859 1884 four days after treatment E30 Date:T53 T54 Medication 1893 1921 continuative pharmacotherapy E31 Medication:T54 A4 POLARITY E31 NEG T55 Date 1926 1946 two months follow-up E32 Date:T55 T56 Sign_symptom 2005 2014 dysphagia E33 Sign_symptom:T56 T57 Sign_symptom 2036 2046 dysarthria E34 Sign_symptom:T57 T58 Sign_symptom 2148 2159 hemiatrophy E35 Sign_symptom:T58 T59 Detailed_description 2129 2135 marked T60 Detailed_description 2136 2147 right-sided R27 MODIFY Arg1:T60 Arg2:E35 R28 MODIFY Arg1:T59 Arg2:E35 T61 Diagnostic_procedure 2106 2123 tongue protrusion E36 Diagnostic_procedure:T61 T62 Lab_value 2066 2098 tongue deviated toward the right R29 MODIFY Arg1:T62 Arg2:E36 T63 Diagnostic_procedure 2204 2213 examation E37 Diagnostic_procedure:T63 T64 Coreference 2221 2250 right hypoglossal nerve palsy E38 Coreference:T64 R30 IDENTICAL Arg1:E38 Arg2:E28 T65 Date 2290 2312 three months follow-up E39 Date:T65 T66 Diagnostic_procedure 2329 2350 vocal cord evaluation E40 Diagnostic_procedure:T66 T67 Subject 2357 2371 ENT specialist R31 MODIFY Arg1:T67 Arg2:E40 T68 Nonbiological_location 2377 2391 local hospital R32 MODIFY Arg1:T68 Arg2:E40 T69 Sign_symptom 2404 2413 paralysis E41 Sign_symptom:T69 A5 POLARITY E41 NEG T70 Biological_structure 2393 2403 Vocal cord R33 MODIFY Arg1:T70 Arg2:E41 T71 Sign_symptom 2470 2481 dysfunction E42 Sign_symptom:T71 T72 Biological_structure 2458 2469 vagus nerve R34 MODIFY Arg1:T72 Arg2:E42 A6 POLARITY E42 NEG T73 Medication 2483 2499 Oral Vitamin B12 E43 Medication:T73 T74 Therapeutic_procedure 1096 1133 microcatheter was subsequently filled E44 Therapeutic_procedure:T74 T75 Medication 1139 1157 dimethyl sulfoxide E45 Medication:T75 R35 MODIFY Arg1:E45 Arg2:E44 T76 Therapeutic_procedure 1183 1191 injected E46 Therapeutic_procedure:T76 T77 Medication 1166 1173 Onyx-18 E47 Medication:T77 R36 MODIFY Arg1:E47 Arg2:E46 T78 Duration 1197 1208 two minutes E48 Duration:T78 R37 MODIFY Arg1:E48 Arg2:E46 T79 Biological_structure 2190 2203 cranial nerve R38 MODIFY Arg1:T79 Arg2:E37 * OVERLAP E1 E2 R39 BEFORE Arg1:E2 Arg2:E4 * OVERLAP E4 E3 E5 R40 BEFORE Arg1:E5 Arg2:E6 * OVERLAP E6 E7 E8 E9 E10 E16 R41 BEFORE Arg1:E16 Arg2:E18 R42 BEFORE Arg1:E18 Arg2:E17 R43 BEFORE Arg1:E17 Arg2:E44 R44 BEFORE Arg1:E44 Arg2:E46 T80 Therapeutic_procedure 1282 1303 injection was stopped E49 Therapeutic_procedure:T80 R45 BEFORE Arg1:E46 Arg2:E49 R46 BEFORE Arg1:E49 Arg2:E20 * OVERLAP E20 E21 E22 R47 MODIFY Arg1:T42 Arg2:E23 R48 MODIFY Arg1:T44 Arg2:E23 R49 MODIFY Arg1:E24 Arg2:E23 R50 BEFORE Arg1:E22 Arg2:E23 * OVERLAP E23 E25 E26 E27 E28 R51 BEFORE Arg1:E28 Arg2:E29 R52 MODIFY Arg1:T52 Arg2:E29 * OVERLAP E29 E30 E31 R53 BEFORE Arg1:E31 Arg2:E32 * OVERLAP E32 E33 E34 E36 E35 E37 E38 R54 BEFORE Arg1:E38 Arg2:E39 * OVERLAP E39 E40 E41 E42 E43 T81 Clinical_event 2547 2556 follow-up E50 Clinical_event:T81 R55 BEFORE Arg1:E43 Arg2:E50